|
NAMS Newamsterdam Pharma Co Nv 1936258 |
| Balance Sheet |
|
Current Assets
|
437,874,000 |
|
Assets
|
439,191,000 |
|
Current Liabilities
|
41,255,000 |
|
Liabilities
|
60,329,000 |
|
Equity
|
378,862,000 |
|
Shares Out
|
90,015,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-121,083,000 |
|
Investing Cash Flow
|
-669,000 |
| Market Analysis |
Market Cap
|
1,417,741,762 |
|
Price
|
23.55 |
|
BVPS
|
4.21 |
|
PB
|
5.60 |
|
EPS
|
-2.64 |
|
PS
|
12.18 |
|
FCF
|
-121,752,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAMS documents filed with the SEC.
NAMS Filings
Clear
